Health scientists from the University of Newcastle's Nutraceuticals Research Group, led by Professor Manohar Garg, are seeking 80 Australian candidates for a new clinical study to reduce systemic inflammation that impacts the body's insulin secretion and function, the root cause of type-2 diabetes.
"This study will use two bio-active compounds that we find in food - curcumin and omega-3 fat. Both are very important anti- inflammatory agents," Garg said in a release post in the university's website on Thursday.
The randomized control trial will test both compounds, with the test candidates being segregated into four groups, one group will get curcumin only, the second will get omega-3 fat only, the third will receive both, and the fourth will serve as a control group.
By Ruchi Singh
reporter
Park Sae-jin
swatchsjp@ajunews.com
